MedPath

iopamidol

Iopamidol Injection, USP, 41%

Approved
Approval ID

69e9ab05-88f8-45f9-8bc1-ed33ab1385f0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 10, 2023

Manufacturers
FDA

Slate Run Pharmaceuticals, LLC

DUNS: 039452765

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

iopamidol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70436-211
Application NumberANDA217134
Product Classification
M
Marketing Category
C73584
G
Generic Name
iopamidol
Product Specifications
Route of AdministrationINTRAVASCULAR
Effective DateOctober 10, 2023
FDA Product Classification

INGREDIENTS (4)

TROMETHAMINEInactive
Quantity: 1 mg in 1 mL
Code: 023C2WHX2V
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
EDETATE CALCIUM DISODIUMInactive
Quantity: 0.26 mg in 1 mL
Code: 25IH6R4SGF
Classification: IACT
IOPAMIDOLActive
Quantity: 408 mg in 1 mL
Code: JR13W81H44
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

iopamidol - FDA Drug Approval Details